Geulah Livshits analyst CHARDAN CAPITAL

Currently out of the existing stock ratings of Geulah Livshits, 169 are a BUY (96.02%), 7 are a HOLD (3.98%).

Geulah Livshits

Work Performance Price Targets & Ratings Chart

Analyst Geulah Livshits, currently employed at CHARDAN CAPITAL, carries an average stock price target met ratio of 29.62% that have a potential upside of 91.97% achieved within 94 days.

Geulah Livshits’s has documented 326 price targets and ratings displayed on 30 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on KRYS, Krystal Biotech at 25-Jul-2025.

Wall Street Analyst Geulah Livshits

Analyst best performing recommendations are on PASG (PASSAGE BIO).
The best stock recommendation documented was for PASG (PASSAGE BIO) at 6/24/2025. The price target of $6 was fulfilled within 20 days with a profit of $5.65 (1614.29%) receiving and performance score of 807.14.

Average potential price target upside

CRSP Crispr Therapeutics AG EDIT Editas Medicine IOVA Iovance Biotherapeutics MRNA Moderna NTLA Intellia Therapeutics RCKT Rocket Pharmaceuticals RGNX Regenxbio KRYS Krystal Biotech SLDB Solid Biosciences LLC TSHA Taysha Gene Therapies  VYGR Voyager Therapeutics FIXX Homology Medicines IMTX Immatics NV LOGC LogicBio Therapeutics TNYA Tenaya Therapeutics VINC Vincerx Pharma PRVB Provention Bio CABA Cabaletta Bio MGTX MeiraGTx Holdings PLC PASG Passage Bio SQZ Sqz Biotechnologies Co ACHL Achilles Therapeutics PLC ADR IMNM Immunome  IMRX Immuneering Corp IPSC Century Therapeutics FDMT 4D Molecular Therapeutics  CRGX CARGO Therapeutics, Common Stock LXEO Lexeo Therapeutics, Common Stock MGX Metagenomi, Common Stock SNTI Senti Biosciences

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$78

$21.74 (38.64%)

$85

17 days ago
(22-Jul-2025)

2/4 (50%)

$12.07 (18.31%)

32

Buy

$81

$24.74 (43.97%)

$81

1 months ago
(08-Jul-2025)

8/23 (34.78%)

$26.18 (47.76%)

214

Buy

$105

$48.74 (86.63%)

$105

1 months 12 days ago
(27-Jun-2025)

23/28 (82.14%)

$57.51 (121.10%)

255

Buy

$65

$8.74 (15.54%)

$65

1 months 12 days ago
(27-Jun-2025)

4/4 (100%)

$17.51 (36.87%)

100

Buy

$86

$29.74 (52.86%)

$86

1 months 12 days ago
(27-Jun-2025)

12/18 (66.67%)

$38.51 (81.09%)

161

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Geulah Livshits is most bullish on?

Potential upside of $65.13 has been obtained for KRYS (KRYSTAL BIOTECH)

Which stock is Geulah Livshits is most reserved on?

Potential downside of -$0.42 has been obtained for PASG (PASSAGE BIO)

What Year was the first public recommendation made by Geulah Livshits?

On 2019

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?